0001654954-20-003678.txt : 20200401 0001654954-20-003678.hdr.sgml : 20200401 20200401144915 ACCESSION NUMBER: 0001654954-20-003678 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200401 DATE AS OF CHANGE: 20200401 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brown Michael J CENTRAL INDEX KEY: 0001035909 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 20764986 MAIL ADDRESS: STREET 1: C/O EURONET WORLDWIDE, INC. STREET 2: 3500 COLLEGE BOULEVARD CITY: LEAWOOD STATE: KS ZIP: 66211 FORMER NAME: FORMER CONFORMED NAME: BROWN MICHAEL J DATE OF NAME CHANGE: 19970317 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2020-03-31 0001645469 Monopar Therapeutics MNPR 0001035909 Brown Michael J 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 true false false Common Stock 2020-03-31 4 M false 322 A 210322 D Common Stock 4111272.88 I See footnote 3 Common Stock 291667 I See footnote 3 Restricted Stock Units 2020-03-31 4 M false 322 0.00 D Common Stock 322 967 D Represents shares acquired on vesting and settlement of restricted stock units. On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement. This is based upon the 4,111,272.88 shares of Monopar common stock that Tactic Pharma LLC indirectly controls through TacticGem LLC. As a manager of Tactic Pharma LLC, Mr. Brown may be deemed to share voting and dispositive power over these 4,111,272.88 shares. Mr. Brown disclaims beneficial ownership of the 4,111,272.88 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein. This is based upon the 291,667 shares of Monopar Common Stock that Tactic Pharma LLC directly owns. As a manager of Tactic Pharma LLC, Mr. Brown may be deemed to share voting and dispositive power over these 291,667 shares. Mr. Brown disclaims beneficial ownership of the 291,667 shares held by Tactic Pharma LLC, except to the extent of his pecuniary interest therein. /s/ Kim R. Tsuchimoto, Attorney-In-Fact 2020-04-01